Merck to announce multi-million dollar investment towards Montréal's life sciences research sector

Join one of Canada's top R&D investors on Monday, November 26, at the Centre Sheraton Montréal

KIRKLAND, QC, Nov. 22, 2012 /CNW Telbec/ - Members of the media are invited to attend a press conference during which a multi-million dollar investment towards the growth of the life sciences research sector in Montréal will be announced in the company of: Élaine Zakaïb, Minister for Industrial Policy and the Banque de développement économique du Québec; Cyril Schiever, President and Managing Director, Merck Canada Inc.; Martin Leblanc, Vice-Chairman of the Board, Montréal InVivo; Dr. Vassilios Papadopoulos, Executive Director and Chief Scientific Officer, Research Institute of the McGill University Health Centre (RI-MUHC); Dr. Jacques Turgeon, Director, CRCHUM and Dr. Jean-Claude Tardif, Director, Montréal Heart Institute Research Centre. The press conference will be followed by a round table featuring Montréal's next generation of researchers.

WHEN:   Monday, November 26th, 2012 at 10:00 a.m.
  10:00 a.m.   Press conference begins
  10:30 a.m.   Q&A
  10:40 a.m.    One-on-one interviews and photo opportunity
  11:15 a.m.   Round table discussion with Montréal's next generation of researchers
  12:30 p.m.  Lunch
 
WHERE:   Centre Sheraton Montréal
  1201 Rene-Levesque West Blvd., Montréal, H3B 2L7
  Drummond Room

 

 

SOURCE: MERCK

For further information:

Stephanie Lyttle
514-843-2365
slyttle@national.ca

Roch Landriault
514-843-2345
rlandriault@national.ca